Viskase Holdings, Inc.
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
333 EAST BUTTERFIELD ROAD, SUITE 400, LOMBARD, IL, 60148
Mailing Address
333 EAST BUTTERFIELD ROAD, SUITE 400, LOMBARD, IL, 60148
Phone
(630) 874-0700
Fiscal Year End
1231
EIN
222372868
Financial Overview
FY2025 FY
$26K
Revenue
$47.17M
Total Assets
$3.01M
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | March 27, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | March 27, 2026 | View on SEC |
| 3 Initial insider ownership report | March 26, 2026 | View on SEC |
| 3 Initial insider ownership report | March 26, 2026 | View on SEC |
| 3 Initial insider ownership report | March 26, 2026 | View on SEC |
| 3 Initial insider ownership report | March 26, 2026 | View on SEC |
| 3 Initial insider ownership report | March 26, 2026 | View on SEC |
| 3 Initial insider ownership report | March 26, 2026 | View on SEC |
| 3 Initial insider ownership report | March 26, 2026 | View on SEC |
| 3 Initial insider ownership report | March 26, 2026 | View on SEC |
Annual Reports
10-K
March 2, 2026
- Enzon has signed a definitive agreement to merge with Viskase Companies, Inc., transforming into Viskase Holdings, Inc.
- The company is pivoting from a pharmaceutical entity to a public acquisition vehicle, facilitating Viskase's public listing.
Material Events
8-K
Acquisition
March 26, 2026
High Impact
- Reverse merger provides immediate public market access without a traditional IPO
- Consolidated focus on core global meat and poultry packaging operations
Related Companies
Companies in the same industry (SIC: 2836)
Scinai Immunotherapeutics Ltd.
SCNI
Biological Products, (No Diagnostic Substances)
Genenta Science S.p.A.
GNTA
Biological Products, (No Diagnostic Substances)
Greenland Mines Ltd
GRML
Biological Products, (No Diagnostic Substances)
Kymera Therapeutics, Inc.
KYMR
Biological Products, (No Diagnostic Substances)
Innate Pharma SA
IPHA
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.